Monograph Title | Section Sort descending | Source Publication | Page Number | Errata Post Date | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
CETIRIZINE HYDROCHLORIDE ORALLY DISINTEGRATING TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 915 | 24-Apr-2020 | 1-May-2020 | NA | NA | In USP Cetirizine Related Compound A RS: Change 506.98 to: 506.97 |
ONDANSETRON TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | Change USP Ondansetron Related Compound A RS 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride. to: USP Ondansetron Related Compound A RS 3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H… Read More |
<121> INSULIN ASSAYS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP41–NF36 | 6054 | 28-Sep-2018 | 1-Oct-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | This erratum applies to the new USP-NF ONLINE platform only. Delete USP Insulin RS |
DOXYCYCLINE FOR INJECTION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
QUAZEPAM | ADDITIONAL REQUIREMENTS/USP Reference standards <11> | USP43–NF38 | 3790 | 30-Jul-2021 | 1-Aug-2021 | NA | NA | In USP Quazepam Related Compound A RS: Change 7-Chloro-1-(2,2,2 trifluoroethyl)-5-(2-Fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one. to: 7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-one. |
DESFLURANE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP42–NF37 | 1230 | 27-Sep-2019 | 1-Oct-2019 | NA | NA | In USP Desflurane Related Compound A RS: Change Bis-(1,2,2,2-tetrafluoroethyl)ether. to: Bis-(1,2,2,2-tetrafluoroethyl)ether; Also known as: 1,1,1,2-Tetrafluoro-2-(1,2,2,2-tetrafluoroethoxy)ethane. |
AZEOTROPIC ISOPROPYL ALCOHOL | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP41–NF36 | 2257 | 30-Nov-2018 | 1-Dec-2018 | USP43–NF38 | USP42–NF37 | Line 1 of USP 2-Propanol System Suitability RS: Change It contains 0.1% of each of the following: ethyl ether, acetone, isopropyl alcohol, diisopropyl ether, 1-propanol, and 2-butanol. to: It is a mixture of the following: ethyl ether (0.1%), acetone (0.1… Read More |
MESNA | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | Second Supplement to USP41–NF36 | 8904 | 22-Feb-2019 | 1-Mar-2019 | NA | NA | In USP Mesna Related Compound A RS: Change 2-(Acetylthio)ethane-1-sulfonic acid. C4H8O4S2 184.22 to: 2-(Acetylthio)ethane-1-sulfonic acid, potassium salt, crystal adduct with potassium chloride. C4… Read More |
MESO-ZEAXANTHIN | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | In USP meso-Zeaxanthin RS: Change (3R,3′S-meso)-Zeaxanthin. to: (3R,3′S)-Zeaxanthin. |
GALANTAMINE EXTENDED-RELEASE CAPSULES | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | First Supplement to USP43–NF38 | Online | 30-Oct-2020 | 1-Nov-2020 | NA | NA | In USP Galantamine Hydrobromide Related Compounds Mixture RS: Change Anhydrogalantamine; (4aS,8aS)-3-Methoxy-11-methyl-9,10,11,12-tetrahydro-4aH-benzo[2,3]benzofuro[4,3-cd]azepine. C17H19NO2 to: … Read More |
DOXYCYCLINE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
GLYBURIDE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 24-Sep-2021 | 1-Oct-2021 | NA | NA | In USP Glyburide Related Compound A RS: Change 4-[2-(5-Chloro-2-methoxybenzamido)ethyl]ben zenesulfonamide. to: 4-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonamide. |
FEXOFENADINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 1869 | 29-Jan-2021 | 1-Feb-2021 | NA | NA | In USP Fexofenadine Related Compound B RS: Change 3-[1-Hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl benzeneacetic acid hydrochloride. C32H39NO4 · HCl 538.12 to: 3-[1-Hydroxy-4-[4-(… Read More |
QUAZEPAM TABLETS | ADDITIONAL REQUIREMENTS/USP Reference standards <11> | USP43–NF38 | 3791 | 30-Jul-2021 | 1-Aug-2021 | NA | NA | In USP Quazepam Related Compound A RS: Change 7-Chloro-1-(2,2,2 trifluoroethyl)-5-(2-Fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one. to: 7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-one. |
WARFARIN SODIUM TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In USP Warfarin Related Compound A RS: Change 3-(o-Hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one. to: 3-(2-Hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one. AND Change 264.33 to: 264.32 |
LEVALBUTEROL INHALATION SOLUTION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP42–NF37 | 2520 | 26-Apr-2019 | 1-May-2019 | NA | NA | In USP Levalbuterol Related Compound D RS: Change 5-[2-{(1,1-Dimethylethyl)amino}-1-hydroxyethyl]-2-hydroxy-benzaldehyde; Also known as 5-[2-{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-(methoxymethyl)-benzenemethanol. C13H… Read More |
MESNA TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | Second Supplement to USP41–NF36 | 8906 | 22-Feb-2019 | 1-Mar-2019 | NA | NA | In USP Mesna Related Compound A RS: Change 2-(Acetylthio)ethane-1-sulfonic acid. C4H8O4S2 184.22 to: 2-(Acetylthio)ethane-1-sulfonic acid, potassium salt, crystal adduct with potassium chloride. C4… Read More |
ELEUTHERO ROOT AND RHIZOME | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 19-Nov-2021 | 1-Dec-2021 | NA | NA | Change USP Eleutheroside B RS β-D-Glucopyranoside, 4-(3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl. C17H24O9 372.37 USP Eleutheroside E RS β-D-Glucopyranoside, (tetrahydro-1H,3H-furo(3,4-c)furan-1,4-… Read More |
DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
SILDENAFIL CITRATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP42–NF37 | 4002 | 30-Aug-2019 | 1-Sep-2019 | NA | NA | In USP Sildenafil Related Compound A RS: Change 5-[2-Ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-(2-methylpropyl)-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one. C23H32N6O4S… Read More |
ATORVASTATIN CALCIUM | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP42–NF37 | 410 | 26-Apr-2019 | 1-May-2019 | NA | NA | In USP Atorvastatin Related Compound A RS: Change Desfluoro impurity, or (3R,5R)-7-[3-(phenylcarbamoyl)-2-isopropyl-4,5-diphenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid, calcium salt. to: Calcium (3R,5R)-7-[2-… Read More |
FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP40–NF35 | 4309 | 30-Mar-2018 | 1-Apr-2018 | USP42–NF37 | USP42–NF37 | Line 2 of USP Salmeterol Related Compound H RS: Change 1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid. C36H43NO6 585.73 to: 1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6… Read More |
ATORVASTATIN CALCIUM | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 31-Dec-2021 | 1-Jan-2022 | NA | NA | In USP Atorvastatin Related Compound C RS: Change C66H66F4N4O10 to: C66H66CaF4N4O10 AND In USP Atorvastatin Related Compound E RS: Change… Read More |
WARFARIN SODIUM FOR INJECTION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In USP Warfarin Related Compound A RS: Change 3-(o-Hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one. to: 3-(2-Hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one. AND Change 264.33 to: 264.32 |
RILUZOLE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 3882 | 26-Mar-2021 | 1-Apr-2021 | NA | NA | In USP Riluzole Related Compound A RS: Change 4-Trifluoromethoxyphenylamine; 4-trifluoromethoxyanaline. C7H6F3NO 177.12 to: 4-(Trifluoromethoxy)aniline. C7H6F3NO 177.… Read More |
ECONAZOLE NITRATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 25-Feb-2022 | 1-Mar-2022 | NA | NA | In USP Econazole Related Compound B RS: Change Econazole amine; 2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethanamine. C15H14Cl3NO 330.64 to: Econazole amine; 2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)… Read More |
ELEUTHERO ROOT AND RHIZOME POWDER | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 19-Nov-2021 | 1-Dec-2021 | NA | NA | Change USP Eleutheroside B RS β-D-Glucopyranoside, 4-(3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl. C17H24O9 372.37 USP Eleutheroside E RS β-D-Glucopyranoside, (tetrahydro-1H,3H-furo(3,4-c)furan-1,4-… Read More |
AZITHROMYCIN FOR ORAL SUSPENSION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In USP Azithromycin Related Compound F RS: Change 762.97 to: 762.98 AND In USP Desosaminylazithromycin RS: Change 590.79 to: 590.80 |
AMLODIPINE AND ATORVASTATIN TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | Revision Bulletin (Official November 27, 2019) | Online | 26-Jun-2020 | 1-Jul-2020 | NA | NA | In USP Atorvastatin Related Compound B RS: Change (3S,5R)-7-[3-(Phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt. to: Calcium (3S,5R)-7-[2-(4-… Read More |
DOXYCYCLINE HYCLATE CAPSULES | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
CLONIDINE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 1100 | 26-Feb-2021 | 1-Mar-2021 | NA | NA | In USP Clonidine Related Compound A RS: Change 1-Acetyl-2-(2,6-dichlorophenylamino)-2-(4,5-dihydroimidazol). to: 1-Acetyl-2-(2,6-dichlorophenylimino)imidazolidine. |
DORZOLAMIDE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 1496 | 30-Jul-2021 | 1-Aug-2021 | NA | NA | In USP Dorzolamide Hydrochloride Related Compound A RS: Change 360.91 to 360.89 |
SUMATRIPTAN | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP42–NF37 | 4139 | 31-May-2019 | 1-Jun-2019 | NA | NA | In USP Sumatriptan Succinate Related Impurities RS: Change Mixture of sumatriptan succinate, [3-[2-(methylamino) ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide maleate salt, sumatriptan succinate related compound C, [3-[2-(dimethylamino… Read More |
MORPHINE SULFATE EXTENDED-RELEASE CAPSULES | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | Revision Bulletin (Official November 01, 2018) | Online | 26-Apr-2019 | 1-May-2019 | NA | NA | In USP Morphine Related Compound B RS: Change 2,2'-Bimorphine. C34H36N2O6 568.66 to: 2,2'-Bimorphine trihydrate. C34H36N2O6 ∙ 3H2O 622.72 |
RILUZOLE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 3883 | 26-Mar-2021 | 1-Apr-2021 | NA | NA | In USP Riluzole Related Compound A RS: Change 4-Trifluoromethoxyaniline. C7H6F3NO 177.12 to: 4-(Trifluoromethoxy)aniline. C7H6F3NO 177.13 |
ELEUTHERO ROOT AND RHIZOME DRY EXTRACT | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 19-Nov-2021 | 1-Dec-2021 | NA | NA | Change USP Eleutheroside B RS β-D-Glucopyranoside, 4-(3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl. C17H24O9 372.37 USP Eleutheroside E RS β-D-Glucopyranoside, (tetrahydro-1H,3H-furo(3,4-c)furan-1,4-… Read More |
ATORVASTATIN CALCIUM | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 414 | 26-Jun-2020 | 1-Jul-2020 | NA | NA | In USP Atorvastatin Related Compound B RS: Change 3S,5R Isomer, or (3S,5R)-7-[3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid, calcium salt. to: Calcium… Read More |
DOXYCYCLINE HYCLATE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
DEXAMETHASONE SODIUM PHOSPHATE INJECTION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP41–NF36 | 1204 | 27-Jul-2018 | 1-Aug-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | Delete USP Endotoxin RS |
ALLOPURINOL | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP41–NF36 | 121 | 30-Nov-2018 | 1-Dec-2018 | USP43–NF38 | USP42–NF37 | Line 3 of USP Allopurinol Related Compound A RS: Change (C5H6N4O)2 · H2SO4 350.32 to: (C4H6N4O)2 · H2SO4 350.31 |
SALMETEROL INHALATION POWDER | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP40–NF35 | 6096 | 30-Mar-2018 | 1-Apr-2018 | USP42–NF37 | USP42–NF37 | Line 2 of USP Salmeterol Related Compound H RS: Change 1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid. C36H43NO6 585.73 to: 1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6… Read More |
SUMATRIPTAN SUCCINATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP42–NF37 | 4145 | 31-May-2019 | 1-Jun-2019 | NA | NA | In USP Sumatriptan Succinate Related Impurities RS: Change Mixture of sumatriptan succinate, [3-[2-(methylamino) ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide maleate salt, sumatriptan succinate related compound C, [3-[2-(dimethylamino… Read More |
CLOMIPRAMINE HYDROCHLORIDE CAPSULES | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | Revision Bulletin (Official July 08, 2020) | Online | 28-Aug-2020 | 1-Sep-2020 | NA | NA | In USP Clomipramine Related Compound A RS: Change 458.89 to: 458.90 |
AMPICILLIN | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 316 | 26-Mar-2021 | 1-Apr-2021 | NA | NA | In USP Amoxicillin Related Compound A RS: Change (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid. C16H14N2O2 266.29 to: (2S,5… Read More |
LORAZEPAM TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP41–NF36 | 2474 | 28-Sep-2018 | 1-Oct-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | Line 3 of USP Lorazepam Related Compound B RS: Change 266.13 to: 266.12 AND Line 4 of USP Lorazepam Related Compound C RS: Change 303.15 to: 303.14 AND Line 4 of USP Lorazepam Related Compound D RS: Change 319.15 to: 319.14 |
CHLOROQUINE PHOSPHATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP42–NF37 | 939 | 30-Aug-2019 | 1-Sep-2019 | NA | NA | In USP Chloroquine Related Compound G RS: Change C18H26Cl3NO · H2SO4 to: C18H26ClN3O · H2SO4 |
PYRANTEL PAMOATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 2 | Online | 24-Sep-2021 | 1-Oct-2021 | NA | NA | In USP Pyrantel Related Compound A RS: Change (Z)-1-Methyl-2-(2-(thiophen-2-yl)vinyl)-1,4,5,6-tetrahydropyrimidine. C34H30N2O6S 594.69 to: (Z)-1-Methyl-2-[2-(2-thiophenyl)vinyl]-1,4,5,6-… Read More |
TELMISARTAN TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP42–NF37 | 4206 | 31-May-2019 | 1-Jun-2019 | NA | NA | In USP Telmisartan Related Compound A RS: Change 1,7’-Dimethyl-2’-propyl-1H,3’H-2,5’-bibenzo[d]imidazole. C19H20N4 304.39 to: 1,7’-Dimethyl-2’-propyl-1H,3’H-2,5’-bibenzo[d]imidazole… Read More |
CLOMIPHENE CITRATE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | First Supplement to USP43–NF38 | Online | 30-Oct-2020 | 1-Nov-2020 | NA | NA | In USP Clomiphene Related Compound A RS: Change (E,Z)-2-[4-(1,2-Diphenylethyl)phenoxy]-N,N-diethylethanamine hydrochloride. to: (E,Z)-2-[4-(1,2-Diphenylethenyl)phenoxy]-N,N-diethylethanamine hydrochloride. |
NORTRIPTYLINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 25-Jun-2021 | 1-Jul-2021 | NA | NA | In USP Amitriptyline Related Compound B RS: Change 295.42 to: 295.43 |